Prince Akwasi Mensah

Array ( [id] => 6736111 [patent_doc_number] => 20030013746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Advanced glycation end-product intermediaries and post-amadori inhibition' [patent_app_type] => new [patent_app_number] => 10/214540 [patent_app_country] => US [patent_app_date] => 2002-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 20667 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013746.pdf [firstpage_image] =>[orig_patent_app_number] => 10214540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258888 [patent_doc_number] => 20020187210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Method of treating chest pain' [patent_app_type] => new [patent_app_number] => 10/214253 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1643 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187210.pdf [firstpage_image] =>[orig_patent_app_number] => 10214253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 988220 [patent_doc_number] => 06921775 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-26 [patent_title] => 'Methods for modulating brain damage' [patent_app_type] => utility [patent_app_number] => 10/213393 [patent_app_country] => US [patent_app_date] => 2002-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 28 [patent_no_of_words] => 13100 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/921/06921775.pdf [firstpage_image] =>[orig_patent_app_number] => 10213393 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745759 [patent_doc_number] => 20030022942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Methods and compositions for treating depression and other disorders using optically pure (-)-bupropion' [patent_app_type] => new [patent_app_number] => 10/202830 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5074 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022942.pdf [firstpage_image] =>[orig_patent_app_number] => 10202830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745714 [patent_doc_number] => 20030022897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Use of cox-2 inhibitors as gastroprokinetics' [patent_app_type] => new [patent_app_number] => 10/182080 [patent_app_country] => US [patent_app_date] => 2002-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4048 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022897.pdf [firstpage_image] =>[orig_patent_app_number] => 10182080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774744 [patent_doc_number] => 20030018082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Use of aminoguanidine or aminoguanidine analogs for the treatment of diseases of the nervous system' [patent_app_type] => new [patent_app_number] => 10/193059 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8277 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018082.pdf [firstpage_image] =>[orig_patent_app_number] => 10193059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 645547 [patent_doc_number] => 07119118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Highly purified ethyl EPA and other EPA derivatives for treatment of huntington\'s disease' [patent_app_type] => utility [patent_app_number] => 10/191430 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10284 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/119/07119118.pdf [firstpage_image] =>[orig_patent_app_number] => 10191430 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7368234 [patent_doc_number] => 20040006109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Liquid dosage forms of non-enterically coated acid-labile drugs' [patent_app_type] => new [patent_app_number] => 10/190240 [patent_app_country] => US [patent_app_date] => 2002-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4085 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006109.pdf [firstpage_image] =>[orig_patent_app_number] => 10190240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870676 [patent_doc_number] => 20030083366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Combination chemotherapy' [patent_app_type] => new [patent_app_number] => 10/187679 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5736 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083366.pdf [firstpage_image] =>[orig_patent_app_number] => 10187679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6660261 [patent_doc_number] => 20030134905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Bupropion to treat viral diseases' [patent_app_type] => new [patent_app_number] => 10/184894 [patent_app_country] => US [patent_app_date] => 2002-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3208 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20030134905.pdf [firstpage_image] =>[orig_patent_app_number] => 10184894 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112941 [patent_doc_number] => 20020173551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Bupropion to treat viral diseases' [patent_app_type] => new [patent_app_number] => 10/178498 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3229 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173551.pdf [firstpage_image] =>[orig_patent_app_number] => 10178498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774689 [patent_doc_number] => 20030018027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Methods and pharmaceutical compositions for preventing problem behaviors of companion animals' [patent_app_type] => new [patent_app_number] => 10/176609 [patent_app_country] => US [patent_app_date] => 2002-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3817 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018027.pdf [firstpage_image] =>[orig_patent_app_number] => 10176609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688854 [patent_doc_number] => 20030032579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Therapeutic use of selective PDE10 inhibitors' [patent_app_type] => new [patent_app_number] => 10/177018 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10054 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032579.pdf [firstpage_image] =>[orig_patent_app_number] => 10177018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048585 [patent_doc_number] => 20020169103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Novel treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG' [patent_app_type] => new [patent_app_number] => 10/175576 [patent_app_country] => US [patent_app_date] => 2002-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3164 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20020169103.pdf [firstpage_image] =>[orig_patent_app_number] => 10175576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6414555 [patent_doc_number] => 20020183389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Highly purified EPA and other EPA derivatives for psychiatric and neurological disorders' [patent_app_type] => new [patent_app_number] => 10/173622 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10321 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183389.pdf [firstpage_image] =>[orig_patent_app_number] => 10173622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 961156 [patent_doc_number] => 06951869 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-10-04 [patent_title] => 'Use of leukotriene receptor antagonist for treatment of scarring' [patent_app_type] => utility [patent_app_number] => 10/170635 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4079 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/951/06951869.pdf [firstpage_image] =>[orig_patent_app_number] => 10170635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7026403 [patent_doc_number] => 20050020482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Methods for modulating gap junctions' [patent_app_type] => utility [patent_app_number] => 10/480685 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6223 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020482.pdf [firstpage_image] =>[orig_patent_app_number] => 10480685 [rel_patent_id] =>[rel_patent_doc_number] =>)